Stock ACE ASCELIA PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

News Ascelia Pharma AB

Equities

ACE

SE0010573113

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:50 2024-04-25 am EDT 		5-day change 1st Jan Change
10.6 SEK +9.84% Intraday chart for Ascelia Pharma AB -23.63% +214.54%
Apr. 10 Ascelia Pharma Reports SPARKLE Image Reading Completion and Expects Headline Results First Half of May 2024 CI
Feb. 09 Ascelia Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ascelia Pharma Draws Down SEK 15 Million Second Tranche Under Existing Loan Facility
AQ
Ascelia Pharma Reports SPARKLE Image Reading Completion and Expects Headline Results First Half of May 2024
AQ
Ascelia Pharma Reports SPARKLE Image Reading Completion and Expects Headline Results First Half of May 2024
CI
Annual Report 2023: Solid Progress with Orviglance Phase 3 Patient Recruitment Completed and Headline Results Expected by May 2024
AQ
Notice of Annual General Meeting in Ascelia Pharma AB
AQ
Ascelia Pharma Q4 2023 - On track with easing financial pressure
AQ
Ascelia Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Transcript : Ascelia Pharma AB, Q4 2023 Earnings Call, Feb 09, 2024
Q4 and Full Year Report 2023: Strengthened Financial Position Ahead of SPARKLE Phase 3 Study Headline Results in May
AQ
Ascelia Pharma Secures Financing of up to SEK 35 Million
AQ
Orviglance Review Article Published in Investigative Radiology
AQ
Nomination Committee Appointed for AGM 2024 in Ascelia Pharma AB
AQ
Ascelia Pharma Announces Start of Image Reading Phase and Re-confirms Phase 3 SPARKLE Results by May 2024
AQ
Ascelia Pharma AB Announces Start of Image Reading Phase and Re- Confirms Phase 3 SPARKLE Results by May 2024
CI
Change in Number of Shares and Votes in Ascelia Pharma AB
AQ
Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 13 November 2023
AQ
Ascelia Pharma resolves on conversion of series C shares into ordinary shares for delivery to participants in incentive program
AQ
Transcript : Ascelia Pharma AB, Q3 2023 Earnings Call, Nov 08, 2023
QUARTERLY REPORT Q3 2023: Re-evaluation of SPARKLE Phase 3 Study Images Progresses According to Plan
AQ
Ascelia Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACE Stock
  4. News Ascelia Pharma AB